Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Clyne

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1986
Plasma requirement for expression of lupus-like anticoagulantL P Clyne
Blut|October 1, 1986
Species specificity of lupus-like anticoagulantsL P Clyne
Archives of Internal Medicine|March 1, 1981
Circulating factor XI antibody and disseminated intravascular coagulationD S Fischer, L P Clyne
Archives of Internal Medicine|May 1, 1988
Time dependency of lupuslike anticoagulantsL P Clyne, P F White
American Journal of Clinical Pathology|May 1, 1986
Circulating anticoagulant to animal plasmas in a cardiac patientL P Clyne, D M Komp
Thrombosis and Haemostasis|July 29, 1984
Correction of clotting factor "deficiencies" in plasma from patients with lupus-like anticoagulantsL P Clyne, C L Honig, N Dainiak
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
Procainamide-induced circulating anticoagulants in a congenitally-deficient factor XI patientL P Clyne, L R Farber, R L Chopyk
American Journal of Hematology|December 1, 1987
Acquired factor XI inhibitors in congenitally deficient patientsS F Schnall, T P Duffy, L P Clyne
The Journal of Infectious Diseases|June 1, 1993
Ancylostoma factor Xa inhibitor: partial purification and its identification as a major hookworm-derived anticoagulant in vitroM Cappello, L P Clyne, P McPhedran, et al.
Archives of Pathology & Laboratory Medicine|June 1, 1993
The lupus anticoagulant. High incidence of 'negative' mixing studies in a human immunodeficiency virus-positive populationL P Clyne, Y Yen, N S Kriz, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1986
Plasma requirement for expression of lupus-like anticoagulantL P Clyne
Blut|October 1, 1986
Species specificity of lupus-like anticoagulantsL P Clyne
Archives of Internal Medicine|March 1, 1981
Circulating factor XI antibody and disseminated intravascular coagulationD S Fischer, L P Clyne
Archives of Internal Medicine|May 1, 1988
Time dependency of lupuslike anticoagulantsL P Clyne, P F White
American Journal of Clinical Pathology|May 1, 1986
Circulating anticoagulant to animal plasmas in a cardiac patientL P Clyne, D M Komp
Thrombosis and Haemostasis|July 29, 1984
Correction of clotting factor "deficiencies" in plasma from patients with lupus-like anticoagulantsL P Clyne, C L Honig, N Dainiak
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
Procainamide-induced circulating anticoagulants in a congenitally-deficient factor XI patientL P Clyne, L R Farber, R L Chopyk
American Journal of Hematology|December 1, 1987
Acquired factor XI inhibitors in congenitally deficient patientsS F Schnall, T P Duffy, L P Clyne
The Journal of Infectious Diseases|June 1, 1993
Ancylostoma factor Xa inhibitor: partial purification and its identification as a major hookworm-derived anticoagulant in vitroM Cappello, L P Clyne, P McPhedran, et al.
Archives of Pathology & Laboratory Medicine|June 1, 1993
The lupus anticoagulant. High incidence of 'negative' mixing studies in a human immunodeficiency virus-positive populationL P Clyne, Y Yen, N S Kriz, et al.
Pageof 2